| Code | Description | Claims | Beneficiaries | Total Paid |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
238,370 |
213,492 |
$16.18M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
37,844 |
35,227 |
$12.42M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
32,181 |
30,443 |
$5.32M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
18,615 |
17,590 |
$4.68M |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
7,155 |
3,572 |
$2.17M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
20,696 |
19,009 |
$918K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,339 |
2,983 |
$768K |
| 62323 |
|
1,180 |
1,076 |
$635K |
| 64615 |
|
3,519 |
3,286 |
$621K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
910 |
820 |
$558K |
| 36415 |
Collection of venous blood by venipuncture |
40,692 |
36,059 |
$485K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
5,094 |
1,250 |
$401K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,408 |
2,318 |
$320K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,149 |
791 |
$265K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
11,363 |
10,043 |
$240K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
4,241 |
4,141 |
$240K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
240 |
167 |
$194K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
1,106 |
1,004 |
$174K |
| 97597 |
|
1,952 |
1,210 |
$142K |
| 80053 |
Comprehensive metabolic panel |
43,426 |
40,194 |
$133K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
3,325 |
732 |
$129K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,467 |
1,170 |
$128K |
| 93325 |
|
2,601 |
2,397 |
$124K |
| G0378 |
Hospital observation service, per hour |
503 |
414 |
$116K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
102 |
96 |
$112K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,674 |
1,558 |
$107K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
232 |
204 |
$104K |
| 93304 |
|
428 |
397 |
$102K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,160 |
1,097 |
$99K |
| J0178 |
Injection, aflibercept, 1 mg |
134 |
112 |
$98K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,569 |
1,013 |
$91K |
| 90870 |
|
181 |
40 |
$83K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,230 |
2,122 |
$81K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
914 |
693 |
$77K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
731 |
665 |
$71K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,821 |
4,418 |
$71K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
312 |
293 |
$63K |
| 93321 |
|
544 |
507 |
$49K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
160 |
146 |
$49K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,848 |
2,192 |
$46K |
| H0035 |
Mental health partial hospitalization, treatment, less than 24 hours |
80 |
12 |
$46K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
124 |
119 |
$43K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,539 |
7,650 |
$42K |
| 59025 |
Fetal non-stress test |
498 |
355 |
$42K |
| 71046 |
Radiologic examination, chest; 2 views |
1,947 |
1,822 |
$41K |
| 71045 |
Radiologic examination, chest; single view |
1,875 |
1,741 |
$40K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
48,723 |
44,685 |
$39K |
| 93296 |
|
2,180 |
2,085 |
$39K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
175 |
152 |
$38K |
| 70450 |
Computed tomography, head or brain; without contrast material |
395 |
371 |
$37K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
283 |
269 |
$33K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
80 |
67 |
$33K |
| G0260 |
Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography |
106 |
82 |
$32K |
| D7140 |
Extraction, erupted tooth or exposed root |
24 |
14 |
$31K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
377 |
374 |
$28K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
143 |
132 |
$28K |
| 90834 |
Psychotherapy, 45 minutes with patient |
915 |
555 |
$28K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
194 |
165 |
$28K |
| 90686 |
|
4,031 |
3,860 |
$28K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,492 |
1,089 |
$26K |
| 64643 |
|
112 |
85 |
$24K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,571 |
1,533 |
$22K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
304 |
297 |
$21K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
273 |
264 |
$21K |
| 64642 |
|
114 |
86 |
$18K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
70 |
60 |
$18K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
246 |
244 |
$18K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
395 |
392 |
$18K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
20 |
12 |
$17K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
76 |
75 |
$16K |
| 11721 |
|
1,681 |
1,614 |
$16K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
187 |
177 |
$16K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
175 |
13 |
$15K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
129 |
120 |
$15K |
| 0002A |
|
491 |
476 |
$15K |
| Q0247 |
Injection, sotrovimab, 500 mg |
15 |
15 |
$15K |
| 0001A |
|
461 |
436 |
$14K |
| 98941 |
Chiropractic manipulative treatment; spinal, 3-4 regions |
625 |
357 |
$13K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
90 |
87 |
$13K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,803 |
1,599 |
$12K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
238 |
203 |
$12K |
| 49083 |
|
20 |
12 |
$12K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
72 |
70 |
$12K |
| 97165 |
|
180 |
170 |
$12K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
83 |
79 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
298 |
289 |
$11K |
| 95886 |
|
108 |
101 |
$11K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
751 |
719 |
$11K |
| 97161 |
|
318 |
290 |
$10K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
3,073 |
2,773 |
$10K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
410 |
395 |
$10K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
185 |
181 |
$9K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
93 |
84 |
$9K |
| 0240U |
|
68 |
65 |
$9K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
73 |
72 |
$8K |
| J3490 |
Unclassified drugs |
1,622 |
1,077 |
$8K |
| 93299 |
|
398 |
387 |
$8K |
| 73630 |
|
303 |
262 |
$8K |
| 95117 |
|
261 |
155 |
$8K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
28 |
28 |
$8K |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
34 |
31 |
$7K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
46 |
43 |
$7K |
| 98940 |
|
301 |
168 |
$7K |
| 93320 |
|
136 |
131 |
$7K |
| 92134 |
|
2,325 |
2,141 |
$7K |
| 92526 |
|
173 |
42 |
$6K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
128 |
122 |
$6K |
| J2704 |
Injection, propofol, 10 mg |
5,129 |
4,331 |
$6K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
39 |
36 |
$6K |
| 76000 |
|
127 |
113 |
$6K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,970 |
1,778 |
$6K |
| 76770 |
|
80 |
77 |
$6K |
| 97162 |
|
144 |
133 |
$6K |
| 73610 |
|
119 |
112 |
$6K |
| 92523 |
|
57 |
54 |
$6K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
73 |
70 |
$5K |
| 82077 |
|
2,612 |
2,372 |
$5K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
50 |
45 |
$5K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
13 |
13 |
$4K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
29 |
26 |
$4K |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
3,726 |
3,327 |
$4K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
189 |
83 |
$4K |
| 96367 |
|
165 |
111 |
$4K |
| 80061 |
Lipid panel |
757 |
730 |
$4K |
| 64644 |
|
14 |
12 |
$4K |
| 20610 |
|
178 |
166 |
$3K |
| 84484 |
|
3,448 |
2,833 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
617 |
599 |
$3K |
| 97810 |
|
106 |
40 |
$3K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
87 |
66 |
$3K |
| 71250 |
|
82 |
77 |
$3K |
| 93298 |
|
106 |
106 |
$3K |
| 92567 |
|
183 |
175 |
$3K |
| 90662 |
|
107 |
98 |
$3K |
| 20611 |
|
24 |
24 |
$3K |
| 17250 |
|
44 |
29 |
$3K |
| 90656 |
|
249 |
247 |
$3K |
| 17110 |
|
14 |
12 |
$3K |
| 73562 |
|
251 |
203 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
363 |
319 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,857 |
1,684 |
$3K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
14 |
14 |
$2K |
| 94060 |
|
12 |
12 |
$2K |
| 97166 |
|
41 |
38 |
$2K |
| 86140 |
|
1,862 |
1,732 |
$2K |
| G0379 |
Direct admission of patient for hospital observation care |
13 |
12 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
236 |
228 |
$2K |
| 0072A |
|
61 |
61 |
$2K |
| J7999 |
Compounded drug, not otherwise classified |
282 |
88 |
$2K |
| 83690 |
|
4,000 |
3,707 |
$2K |
| Q3014 |
Telehealth originating site facility fee |
210 |
186 |
$2K |
| 90480 |
|
100 |
95 |
$2K |
| 73130 |
|
29 |
27 |
$2K |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
361 |
338 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,983 |
3,665 |
$2K |
| 93226 |
|
27 |
26 |
$2K |
| 87210 |
|
51 |
51 |
$2K |
| 88304 |
|
93 |
77 |
$2K |
| 51798 |
|
57 |
55 |
$2K |
| 99173 |
|
27 |
26 |
$2K |
| 81001 |
|
3,363 |
3,095 |
$1K |
| 86780 |
|
97 |
95 |
$1K |
| 0054A |
|
65 |
62 |
$1K |
| 0071A |
|
42 |
41 |
$1K |
| V2632 |
Posterior chamber intraocular lens |
508 |
323 |
$1K |
| 82805 |
|
354 |
324 |
$1K |
| 93971 |
|
30 |
27 |
$1K |
| 90717 |
|
13 |
12 |
$1K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,869 |
1,531 |
$1K |
| 96116 |
|
16 |
12 |
$1K |
| 84702 |
|
1,446 |
1,319 |
$1K |
| 97602 |
|
21 |
12 |
$1K |
| 73110 |
|
45 |
41 |
$1K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
38 |
38 |
$1K |
| 83735 |
|
2,566 |
2,282 |
$1K |
| 97116 |
|
71 |
28 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,081 |
6,007 |
$1K |
| 96415 |
|
14 |
12 |
$1K |
| 0124A |
|
43 |
42 |
$1K |
| 87631 |
|
197 |
194 |
$1K |
| 0004A |
|
47 |
43 |
$983.97 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,501 |
3,122 |
$975.32 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,944 |
2,543 |
$966.97 |
| 85027 |
|
3,006 |
2,732 |
$954.84 |
| 99188 |
|
594 |
567 |
$945.43 |
| 83605 |
|
910 |
801 |
$864.73 |
| 0052A |
|
25 |
24 |
$845.17 |
| 92611 |
|
14 |
13 |
$840.88 |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
17 |
17 |
$732.00 |
| 95874 |
|
62 |
45 |
$717.54 |
| 86850 |
|
147 |
132 |
$649.14 |
| 99411 |
|
14 |
14 |
$581.84 |
| 95115 |
|
22 |
12 |
$572.35 |
| G0008 |
Administration of influenza virus vaccine |
136 |
134 |
$563.68 |
| 91320 |
|
13 |
13 |
$560.79 |
| 0051A |
|
17 |
16 |
$560.48 |
| 83880 |
|
211 |
200 |
$552.50 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
324 |
269 |
$552.27 |
| 84703 |
|
1,026 |
967 |
$530.71 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
296 |
274 |
$530.40 |
| 77003 |
|
62 |
56 |
$505.50 |
| 86803 |
|
39 |
39 |
$504.52 |
| 74230 |
|
14 |
13 |
$499.80 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
50 |
50 |
$499.69 |
| D0140 |
Limited oral evaluation - problem focused |
25 |
25 |
$468.73 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
297 |
279 |
$444.17 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
150 |
139 |
$399.40 |
| 88342 |
|
17 |
15 |
$367.15 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,103 |
2,562 |
$360.70 |
| 94664 |
|
358 |
334 |
$356.67 |
| 92136 |
|
43 |
41 |
$338.67 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
14 |
14 |
$337.08 |
| 86900 |
|
163 |
143 |
$325.17 |
| 94729 |
|
27 |
27 |
$315.42 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
15 |
15 |
$305.88 |
| 97035 |
|
54 |
26 |
$280.91 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
201 |
124 |
$272.38 |
| 81025 |
|
139 |
131 |
$265.64 |
| 73564 |
|
13 |
12 |
$258.39 |
| 73030 |
|
46 |
46 |
$250.70 |
| 92133 |
|
56 |
53 |
$249.58 |
| 82784 |
|
26 |
25 |
$238.50 |
| 85652 |
|
355 |
333 |
$210.05 |
| 36416 |
|
126 |
117 |
$201.50 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,089 |
934 |
$200.07 |
| 90691 |
|
12 |
12 |
$188.28 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
13 |
$179.08 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
13 |
13 |
$179.08 |
| 83550 |
|
53 |
52 |
$177.35 |
| 85610 |
|
983 |
890 |
$175.66 |
| 86901 |
|
162 |
142 |
$174.50 |
| 84439 |
|
25 |
25 |
$162.87 |
| 82570 |
|
133 |
118 |
$155.52 |
| 83540 |
|
40 |
40 |
$150.23 |
| 72100 |
|
29 |
25 |
$144.30 |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
28 |
25 |
$139.12 |
| 91305 |
|
15 |
13 |
$127.15 |
| 94010 |
|
45 |
41 |
$124.36 |
| 91300 |
|
128 |
99 |
$118.38 |
| 80050 |
General health panel |
30 |
28 |
$100.16 |
| 82728 |
|
70 |
69 |
$96.19 |
| 83615 |
|
175 |
149 |
$92.72 |
| 74018 |
|
63 |
62 |
$91.01 |
| 80197 |
|
21 |
13 |
$85.15 |
| C9257 |
Injection, bevacizumab, 0.25 mg |
54 |
49 |
$78.83 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
546 |
410 |
$78.53 |
| 96376 |
|
457 |
326 |
$76.39 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
18 |
12 |
$76.30 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
15 |
15 |
$66.15 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
174 |
150 |
$57.68 |
| 81003 |
|
619 |
572 |
$47.56 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
246 |
193 |
$27.75 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
160 |
138 |
$16.68 |
| J2060 |
Injection, lorazepam, 2 mg |
161 |
134 |
$5.76 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
42 |
39 |
$0.64 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,779 |
1,373 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
219 |
98 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
62 |
42 |
$0.00 |
| 80179 |
|
61 |
56 |
$0.00 |
| 80143 |
|
79 |
71 |
$0.00 |
| 82565 |
|
101 |
92 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
143 |
137 |
$0.00 |
| 87186 |
|
146 |
123 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
173 |
161 |
$0.00 |
| 85014 |
|
28 |
26 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
67 |
55 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
37 |
24 |
$0.00 |
| 80076 |
|
31 |
27 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
24 |
24 |
$0.00 |
| 90715 |
|
12 |
12 |
$0.00 |
| 84100 |
|
13 |
13 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
58 |
39 |
$0.00 |
| 84156 |
|
18 |
13 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
110 |
95 |
$0.00 |
| C1769 |
Guide wire |
343 |
306 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
217 |
152 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
260 |
232 |
$0.00 |
| 85379 |
|
104 |
98 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
76 |
39 |
$0.00 |
| 82607 |
|
42 |
38 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
15 |
13 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
133 |
119 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
43 |
40 |
$0.00 |
| 85018 |
|
158 |
132 |
$0.00 |
| 87077 |
|
164 |
131 |
$0.00 |
| 73502 |
|
41 |
38 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
46 |
43 |
$0.00 |
| A9270 |
Non-covered item or service |
1,814 |
467 |
$0.00 |
| 87070 |
|
94 |
80 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
38 |
38 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
44 |
43 |
$0.00 |
| 85730 |
|
59 |
52 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
68 |
53 |
$0.00 |
| 87040 |
|
153 |
98 |
$0.00 |
| 80069 |
|
224 |
176 |
$0.00 |
| 97535 |
Self-care/home management training, each 15 minutes |
61 |
43 |
$0.00 |
| 87205 |
|
15 |
12 |
$0.00 |
| 80047 |
|
25 |
24 |
$0.00 |
| 84132 |
|
28 |
25 |
$0.00 |
| 82550 |
|
54 |
47 |
$0.00 |
| G0009 |
Administration of pneumococcal vaccine |
28 |
28 |
$0.00 |
| 82043 |
|
17 |
16 |
$0.00 |